AEGiS-PRn: Dr. David Ho, World-Renowned HIV/AIDS Researcher and Time Magazine's '1996 Man Of The Year' to Serve as Senior HIV/AIDS PRNewswireImportant note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Click here to return to PRNewswire main menu
DonateNow
Print this article

Dr. David Ho, World-Renowned HIV/AIDS Researcher and Time Magazine's '1996 Man Of The Year' to Serve as Senior HIV/AIDS

PR Newswire, 810 Seventh Avenue, New York, NY 10019 - May 1997.


LOS ANGELES, May 15 /PRNewswire/ -- Dr. David Ho, world-renowned HIV /AIDS researcher, and Time magazine's "1996 Man Of The Year," will be senior consultant for the BENTLEY HEALTH CARE, Inc. HIV /AIDS division. Dr. Ho has been internationally recognized for his groundbreaking work with protease inhibitors, which in combination with standard anti-viral medications has provided a dramatic new direction for the treatment of HIV / AIDS patients .

BENTLEY HEALTH CARE, Inc. is the newly created global health care company of Dr. Bernard Salick, the disease-state management visionary and former Chairman and CEO of Salick Health Care, Inc. Dr. Salick is highly acclaimed for his pioneering approach to quality, cost-effective, state-of-the-art outpatient diagnostic and treatment centers. He is credited with the development of innovative concepts that have fundamentally altered the way cancer care is delivered in the United States. He is also recognized as a leading expert in managed care and disease-state management.

As Senior HIV /AIDS Consultant, Dr. Ho will provide BENTLEY HEALTH CARE with strategic advice in the areas of practice guidelines, outcomes measurements, and treatment protocols which will be used in the development of a data base for capitated and other types of managed care products. He will head up the HIV /AIDS scientific advisory group that will advise Dr. Salick in the development of affiliated networks of basic science and clinical treatment centers throughout the world.

Upon announcing the affiliation, Dr. Salick stated, "I am very pleased that a physician and researcher of Dr. Ho's stature and accomplishments has decided to be a key member of the Bentley Health Care consulting team and will provide such a critical range of services."

Dr. Ho, whose ingenious combination anti-viral "cocktail" treatment has captured worldwide interest, has been performing landmark investigation of HIV infection since the mid-1980s. His research has produced a wealth of vital information on how HIV attacks and eventually overwhelms the immune system . His experimental work, alone and in cooperation with others, has expanded the frontiers of knowledge regarding HIV and AIDS and opened exciting new directions for treatment.

BENTLEY HEALTH CARE, Inc. is a Beverly Hills-based global health care company that will provide diagnostic and therapeutic services to patients with catastrophic illnesses requiring sophisticated long-term care in cancer, AIDS, kidney failure, and organ transplantation. It will also enter into negotiations with state, federal and local governments both here and in Europe in the areas of Medicare, Medicaid, Champas and other government health plans, Managed Care and the E.C. Nation Health Service. The company is dedicated to advancing the field of disease-state management, offering innovative and unique solutions to patients, physicians and payees seeking quality patient care and cost-effective disease-state program management.

CONTACT: Ron Wise of Bentley Health Care, 310-248-3300


Keywords: HIV; PROTEASE; AIDS PATIENTS; IMMUNE SYSTEM

Copyright (c) 1997/PR NewsWire. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, PR Newswire, 810 Seventh Avenue, New York, NY 10019.KWDhiv;protease;aidspatients;immunesystem
970515
PR970533


Copyright © 1997 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019  http://www.prnewswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .